CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Relation between frailty and clinical outcomes in elderly patients with COVID-19.Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D000073496 Frailty NIH 0.45

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Relationship Between Frailty and Clinical Outcomes in Elderly Patients With COVID-19

This is a monocentric retro-prospective observational study that wants to evaluate the relation between frailty and clinical outcomes in elderly patients with COVID-19.

NCT04412265 Covid19 Other: Relation between frailty and clinical outcomes in elderly patients with COVID-19.
MeSH:Frailty

Primary Outcomes

Description: The aim of the project is to evaluate whether a tool built to measure frailty in elderly patients admitted to the COVID + hospital wards of San Gerardo hospital is more accurate in predicting clinical states than a clinical evaluation developed on age and comorbidity.

Measure: Development of a tool to measure frailty

Time: Until patient discharge from the hospital (approximately 1 year).

Secondary Outcomes

Description: Assess whether a "proxy" variable of the fragility index can be built on the basis of regional administrative databases only, which is able to predict the clinical outcomes of COVID + patients better than age and comorbidities alone.

Measure: A "proxy" variable of the fragility index can be built on the basis of regional administrative databases only.

Time: Until patient discharge from the hospital (approximately 1 year).

Description: Relate different levels of chronicity with the susceptibility of the elderly subject to infection to give elements to focus the screening policies for COVID19.

Measure: Give elements to focus the screening policies for COVID19.

Time: Until patient discharge from the hospital (approximately 1 year).

Description: Relate different levels of chronicity with the susceptibility of the elderly subject to infection to prevent the contagion at the elderly population level.

Measure: Give the prevention of contagion at the elderly population level.

Time: Until patient discharge from the hospital (approximately 1 year).


No related HPO nodes (Using clinical trials)